J. Fac. Pharm. Istanbul / İstanbul Ecz. Fak. Derg.
46(2) 2016 pp.71-78
Original Article
The difference between the extracts of Erica manipuliflora in
flowering and fruiting periods in terms of the cytotoxic effects
Burcu Sen1,*, Sonja Kessler2, Bahar Gurdal3, Alexandra Kiemer2, Afife Mat1
1
2
Department of Pharmacognosy, Faculty of Pharmacy, Istanbul University, 34116,
Istanbul, Turkey
Department of Pharmacy, Pharmaceutical Biology, Saarland University, Saarbrucken,
Germany
3
Department of Pharmaceutical Botany, Faculty of Pharmacy, Istanbul University,
34116, Istanbul, Turkey
Abstract: The genus Erica comprises five species (E. arborea, E. bocquetii,
E. manipuliflora, E. sicula, E. spiculifolia), in Turkey. In traditional Turkish
medicine, the aerial parts of E. arborea and E. manipuliflora are used as diuretic
and astringent and in the treatment of urinary infections. Additionally, the
decoction of E. manipuliflora is used as weight-loss medicine, diuretic and in
the treatment of diabetes, in Mugla (Turkey) and Western Mediterrenean Region
in Turkey. This present study aimed to determine the cytotoxicity potentials of
different extracts from this species and compare the cytotoxicity between its
flowering and fruiting periods.
Key words: Erica manipuliflora, cytotoxicity, HepG2, HUVEC
*Correspondence: burcusn@gmail.com
Introduction
The genus Erica L. (Ericaceae) is represented by more than 700 species
worldwide. In Turkey, it comprises five species (E. arborea, E. bocquetii,
E. manipuliflora, E. sicula, E. spiculifolia). E. manipuliflora Salisb.
is commonly distributed in all coasts of Turkey (Davis, 1978; Güner et
al., 2012). These species are commonly known as “funda”, “püren” or
“süpürge çalısı” in Turkey (Baytop, 1999). In traditional Turkish medicine,
the aerial parts of E. arborea and E. manipuliflora are used as diuretic
and astringent and in the treatment of urinary infections and the infusion
(5%) of E. arborea as a weight-loss measure. Additionally, the decoction
72
The difference between the extracts of Erica manipuliflora in flowering and fruiting
periods in terms of the cytotoxic effects
of E. manipuliflora is used as weight-loss medicine, diuretic and in the
treatment of diabetes, in Mugla (Turkey) and Western Mediterranean
Region in Turkey (Başer et al., 1986; Baytop, 1999; Tuzlacı & Eryaşar
Aymaz, 2001; Fakir et al., 2009; Sağıroglu et al., 2013). The species of
this genus contain flavonoids, anthocyanidols, coumarins and triterpenic
compounds (Ballester et al., 1975; Bennini et al., 1993; Chulia et al., 1995;
Crowden & Jarman, 1976; Mendez, 1978; Vieitez et al., 1972.). Cytotoxic,
anticarcinogenic, antiulcer, and antimicrobial activities of some Erica
species were reported (Carballeira, 1982; Toro Sainz et al., 1987; Reyes
Ruiz et al., 1996; Oddo et al., 1999; Martin-Cordero et al., 2001).
In a study, the inorganic compounds of 4 species (E. arborea, E.
manipuliflora, E. bocquetii and E. sicula subsp. libanotica) were
investigated and in these four Erica species the concentrations of Cd, As
and Pb were found lower than the permissible levels as stated by WHO
(World Health Organization) (Güvenç et al., 2007).
Küpeli Akkol et al. (2008) investigated the antiinflamatory and
antinociceptive activities of 4 Erica species, one of them was E.
manipuliflora and remarked that, the ethyl acetate extracts of Erica
manipuliflora exhibited notable inhibition against carrageenan-induced
(29.2-35.1%) and Prostaglandin E2 (PGE2)-induced (6.2-34.1%) hind paw
edema as well as 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced
mouse ear edema models in mice and also that, this extract was found
to exhibit remarkable antinociceptive activity in p-benzoquinone-induced
abdominal constriction test at a dose of 100mg/kg (36.3%).
In a project to investigate the antioxidant activities of 4 Erica species
grown in Turkey, their total fenolic contents and their antioxidant activities
by DPPH and TBA assays were determined. The ethyl acetate extracts of
all species were the most active ones. E. manipuliflora was determined as
the most active species among all of them (Güvenç A., 2007).
The volatile constituents of E. manipuliflora were determined by Tzitsa
et al. from Dirfis and Taygetos mountains (Greece). The major compounds
of the essential oil from Dirfis mountain were heptacosane (19.9%), benzyl
salicylate (9.9%), nonacosane (8.9%) and caryophyllene oxide (8.7%) and
from Taygetos mountain l-octen-3-ol(16.2%), nonanal (9.8%), n-octanol
(7.7%) and β-caryophyllene (7.5%) (Tzitsa et al., 2000).
B.ŞEN, S. KESSLER, B. GÜRDAL, A. KIEMER, A. MAT
73
Because of the minority of the studies on this species and lack of a
study on the cytotoxicity of E. manipuliflora and a comparison between its
flowering and fruiting periods, it is aimed to improve the knowledge about
this plant, to determine the cytotoxicity potentials of different extracts
from this species.
Materials and methods
Plant material
The aerial parts of Erica manipuliflora in flowering period were collected
from A2(A) Istanbul – Burgaz Adası (Turkey) and in fruiting period from
Istanbul – Kınalı Ada (Turkey), in November 2013 and identified by Dr. Pharm.
Bahar Gürdal. The voucher specimen has been deposited in the Herbarium of
the Faculty of Pharmacy, Istanbul University (ISTE 110340; 110341).
Preparation of extracts
The dried and powdered aerial parts of the species in flowering and
fruiting periods were successively macerated with petroleum ether
(FLM1PE and FRM1PE), acetone (FLM1Ac and FRM1Ac) and ethanol
(FLM1EtOH and FRM1EtOH), with stirring for 1 day. Furthermore,
two portions of the aerial parts were individually macerated with ethanol
(FLM2 and FRM2) and water (FLM3 and FRM3), with stirring for 1 day.
An infusion was prepared from another portion with boiled water (I1). The
extract was stored at ± 4°C after preparation.
Biological Assays
Cell lines, culture conditions and treatments: Roswell Park Memorial
Institute Medium 1640 (RPMI-1640) with glutamine, 10% FCS and
penicillin / streptomycin mixture was used for the human liver carcinoma
cells (HepG2; HB-8065). Primary human umbilical vein endothelial cells
(HUVEC; umbilical veins of patients, ethiknumber: #131/08) were isolated
from umbilical cords by digestion with 0.01% collagenase A solution
(Roche) and grown in Endothelial Cell Growth Medium with supplement
mix (Promocell; C-39215) containing 10% FCS, penicillin (100 U/mL)
/ streptomycin (100 mg/mL) mixture, and kanamycine (50 mg/mL).
Umbilical cords were obtained with the consent of patients (permission by
the local ethics committee). All cells were grown at 37°C and 5% CO2 in a
humidified cell incubator. The culture medium was changed every 2 days.
74
The difference between the extracts of Erica manipuliflora in flowering and fruiting
periods in terms of the cytotoxic effects
The monolayer cells grown to 75–85% confluence were detached with
trypsin-ethylenediamine tetraacetic acid to make single cell suspensions
and the viable cells were determined using the trypan blue exclusion test
and diluted with medium to give a final density of 105 cells/mL. The passage
number range for HepG2 cell lines was maintained between 21 and 26.
The passage number for primary HUVEC cells was maintained between 3
and 5. The extracts were initially dissolved in dimethylsulfoxide (DMSO)
and the stock solution of each extract was prepared at the concentration
of 20 mg/mL. Further, the stock solutions were diluted in the medium to
obtain final concentrations of 0.01-0.15 mg/mL. 100 µL of cell suspension
per well were seeded into 96-well plates at plating density of 104 cells/
well for the HepG2 cells and 2x104 cells/well for HUVEC and incubated
to allow for cell attachment at 37°C and 5% CO2 for 24 h. After 24 h,
the medium was aspirated and the cells were treated with 100 µL serial
concentrations of all extracts. The plates were incubated at 37°C and 5%
CO2 for 24 h. The medium without samples (negative control); 20% ethanol
(positive control) and with 1% and 2% DMSO (solvent) served as controls.
When controlling cell viability in the presence of solvent, concentrations
of up to 0.75% DMSO were shown to be nontoxic. For each extract, all
concentrations were tested n=2 or n=3 in quadruplicate. After 24 h, the
cells in each well were quantified by MTT (3-[4,5-dimethylthiazol-2-yl]2,5-diphenyl-tetrazolium bromide) test (Mosmann, 1983; Kiemer et al.,
2002; Diesel et al., 2011; Kessler et al., 2013).
Cytotoxicity studies: For MTT tests, the medium was aspirated and
the cells were then incubated with 150 µL MTT (0.5 mg/mL in medium)
solution for 3 h. After the removing of the MTT solutions, the formed
formazan crystals were solubilised in 80 µL of DMSO and then the
absorbance was measured at 550 nm and at 690 nm as control wavelength
using a microplate reader.
The cell viability in treated cells compared to that of negative control
cells was calculated. Then, the half maximal inhibitory concentration
(IC50) was expressed as the sample concentration that caused an inhibition
of 50% in cytotoxicity in the cells calculated. The percentage cell viability
was calculated with respect to solvent control as follows (LIT):
% Cell viability = Abs Extract / Abs Solvent Control x 100
The results were expressed IC50 compared to the negative control.
B.ŞEN, S. KESSLER, B. GÜRDAL, A. KIEMER, A. MAT
75
Results and discussion
The cytotoxicity of the extracts was investigated against the HepG2
cells and HUVEC cells. As a first step, the extracts were tested against
HepG2 cell line. Then the extracts, which showed good cytotoxic activity,
were applied on HUVEC cells for the aim to determine the effectiveness
on the healthy human cells.
Six extracts (FLM1EtOH, FLM2, FLM3, FRM1PE, FRM1EtOH,
FRM2) exhibited more activity among other extracts. By the control of
cell viability in the presence of solvent, concentrations of up to 0.75%
DMSO were shown to be nontoxic. So, only FLM1EtOH, FRM1PE and
FRM1EtOH extracts gave good results, but it can be realized that, the other
three extracts showed a few activities besides the toxicity of DMSO. IC50
values of FLM1EtOH, FRM1PE and FRM1EtOH extracts were 0.08195
mg/mL, 0.1037 mg/mL and 0.05918 mg/mL on HepG2, respectively.
Then, the cytotoxic extracts were investigated for their effectiveness on
HUVEC. The FLM1EtOH exhibited cytotoxicity on HUVEC cells at the
concentration of 0.1451 mg/mL, while the cytotoxic concentrations of the
other extracts (FRM1PE and FRM1EtOH) were 0.171 mg/mL and 0.06279
mg/mL, respectively. These extracts were found nontoxic on HUVEC at
the cytotoxic concentrations against HepG2 by using MTT method. The
results of the cytotoxic tests were showed in Table 1.
Table 1. The IC50 values (mg/mL) of the extracts in MTT tests against HepG2 and
HUVEC cell lines
Extracts
IC50 (HepG2; mg/mL)
FLM1PE
0,2663
FLM1Ac
4,427
FLM1EtOH
0,08195
FLM2
0,1723
FLM3
0,2602
I1
0,3522
FRM1PE
0,1037
FRM1Ac
0,2363
FRM1EtOH
0,05918
FRM2
0,178
FRM3
1,38
I2
0,4454
DMSO
0,4924
* have not been measured
IC50 (HUVEC; mg/mL)
*
*
0,1451
0,06504
*
*
0,171
*
0,06279
0,06704
*
*
4,764
76
The difference between the extracts of Erica manipuliflora in flowering and fruiting
periods in terms of the cytotoxic effects
There is an investigation, which informed on in vitro antimicrobial,
antioxidant and cytotoxic activities of n-hexane, ethanol, methanol, ethyl
acetate and aqueous extracts of the aerial parts of Erica arborea L. and
Erica bocquetii P.F. Stevens (endemic species for Turkey) in literature.
It was found that, any extracts of these Erica species showed a cytotoxic
activity on brine shrimp (Artemia salina) (Kıvçak et al., 2013). Villareal
et al. (2013) reported that lup-20(29)-en-3-one, the active component
from the leaves of E. multiflora stimulates melanogenesis in B16 murine
melanoma cells through the inhibition of phosphorylated extracellular
signalregulated kinases 1 and 2 (ERK1/2) activation and showed this
compound as possible therapeutic agent to address hypopigmentation
disorders. Two pentacyclic triterpenoids (ursolic acid and alpha-amyrine),
isolated from the methanolic extract of E. andavalensis aerial parts, have
investigated for their cytotoxic potentials against renal adenocarcinoma
(TK-10), breast adenocarcinoma (MCF-7) and melanoma (UACC-62)
and ursolic acid exhibited the highest cytotoxicity (Martin-Cordero et al.,
2001).
These existing studies give the first signals to the cytotoxic potential
of Erica species, but there are still quite few studies about the cytotoxic
potential of these species. Also, the investigations on E. manipuliflora are
not so much. Beside of these, there is no study on the cytotoxicity of this
species and on a comparison between the activities of its flowering and
fruiting periods.
Upon analyzing the IC50 values, it can be seen that, the hexane extract
(FRM1PE) of the plant in fruiting period was two times more cytotoxic
than the hexane extract of the plant in flowering period (FLM1PE). The
ethanol extracts (FLM1EtOH and FRM1EtOH), which obtained from the
gradient maceration, were the most active two extracts among all extracts;
but the cytotoxicity in fruiting period was higher than in flowering period.
According to all, it can be realized that, this species contains cytotoxic nonpolar compounds, especially in fruiting period, and the polar compounds,
which exist the plant in fruiting period as well as in flowering period.
Generally, it is designated that, the extracts in fruiting period showed
higher cytotoxicity than the extracts in flowering period. The studies will
be continued in this way and improved on the cytotoxic potential of the
extracts and isolated compounds against various cancer cell lines.
B.ŞEN, S. KESSLER, B. GÜRDAL, A. KIEMER, A. MAT
77
Acknowledgements
Burcu Sen thanks the Tincel Vakfi for a fellowship to do a part of this study in
Saarbruecken (Germany).
References
Ballester A, Verwey A, Ovbreem JC (1975) 2-hydroxyphenylacetic acid and 2,
4-dihydroxyphenyl acetonitrile from Erica scoparia. Phytochem., 14: 1667-1668.
Başer KHC, Honda G, Miki W (1986) Herb Drugs and Herbalists in Turkey. Institute
for the Study of Languages and Cultures of Asia and Africa, Tokyo: Studia Culturae
Islamicae. 27.
Baytop T. (1999). Türkiye’de Bitkilerle Tedavi (Geçmişte ve Bugün). Nobel Tip
Kitabevleri Ltd., Istanbul.
Bennini B, Chulia AJ, Kaouadji M, Delage C (1993) Phytochemistry of the Ericaceae 4.
(2R,3R) dihydroflavonol aglycone and glycosides from Erica cinerea. Phytochem., 33:
1233-1236.
Carballeira A (1982) Phytotoxicity of Erica australis L. from heathland soils. An. Edafol.
Agrobiol., 41: 2287-2294.
Chulia A, Benini B, Kaouadji M, Allais DP, Delage C (1995) Two flavonol conjugates
from Erica cinerea. J. Nat. Prod., 58: 560-563.
Crowden RK, Jarman JR (1976) Anthocyanins in the genus Erica. Phytochem., 15: 17961797.
Davis PH (ed.) (1978) Flora of Turkey and the East Aegean Islands. Vol. 6, Edinburgh
University Press, Edinburgh.
Diesel B, Ripoche N, Risch RT, Tierling S, Walter J, Kiemer AK (2011) Inflammationinduced up-regulation of TLR2 expression in human endothelial cells is independent of
differential methylation in the TLR2 promoter CpG island. Innate Immun., 18: 112-123.
Fakir H, Korkmaz M, Güller B (2009) Medicinal plant diversity of western mediterrenean
region in Turkey. JAEBS, 3: 33-43.
Güner A, Aslan S, Ekim T, Vural M, Babaç MT (eds.)(2012) Türkiye Bitkileri Listesi
(Damarlı Bitkiler). Nezahat Gökyiğit Botanik Bahçesi ve Flora Araştırmaları Derneği
Yayını.
Güvenç A (2007) Türkiye’de Yetişen Erica L. Türlerinin Antioksidan Etkilerinin Tayini.
Ankara Üniversitesi Bilimsel Araştırma Projesi - Proje No: 2003 08 03 044.
Güvenç A, Kendir G, Eken A, Aydın A (2007) Evaluation of Inorganic Compounds of
Erica L. Species (Ericaceae) Native to Turkey. FABAD J. Pharm. Sci., 32: 121-125.
78
The difference between the extracts of Erica manipuliflora in flowering and fruiting
periods in terms of the cytotoxic effects
Kessler SM, Pokorny J, Zimmer V, Laggai S, Lammert F, Bohle RM, Kiemer AK (2013)
IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic
action is independent of IGF2/PI3K signaling. Am. J. Physiol. Gastrointest. Liver
Physiol., 304: 328-336.
Kıvçak B, Fafal-Erdoğan T, Gönenç T, Pabuçcuoğlu A, Oran E, Kahraman F, Öztürk
T (2013) Antioxidant, Antimicrobial and Cytotoxic Activities of Erica bocquetii P.
F. Stevens and Erica arborea L. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi /
Gümüşhane University Journal of Health Sciences, 2: 52-65.
Kiemer AK, Weber NC, Fürst R, Bildner N, Kulhanek-Heinze S, Vollmar AM (2002)
Inhibition of p38 MAPK Activation via Induction of MKP-1 Atrial Natriuretic Peptide
Reduces TNF-–Induced Actin Polymerization and Endothelial Permeability. Circ. Res.,
90: 874-881.
Küpeli Akkol E, Yeşilada E, Güvenç A (2008) Valuation of anti-inflammatory and
antinociceptive activities of Erica species native to Turkey. J. Ethnopharmacol., 116:
251-257.
Martin-Cordero C, Reyes M, Ayuso MJ, Toro MV (2001) Cytotoxic triterpenoids from
Erica andevalensis. Z. Naturforsch. C., 56: 45-48.
Mendez J (1978) Isofraxidin in Erica flowers. Phytochem., 17: 820.
Mosmann T (1983) Rapid Colorimetric Assay for Cellular Growth and Survival:
Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods, 65: 55-63.
Oddo LP, Piazza MG, Pulcini P (1999) Invertase activity in honey. Apidologie, 30: 57-65.
Reyes Ruiz M, Martin-Cordero C, Ayuso Gonzalez MJ, Toro Sainz MV, Alarcon de la
Lastra C (1996) Antiulcer activity in rats by flavonoids of Erica andevalensis CabezudoRivera. Phytother. Res., 10: 300-303.
Sağıroglu M, Dalgıc S, Toksoy S (2013) Medicinal plants used in Dalaman (Muğla),
Turkey. J. Med. Plant Res., 7: 2053-2066.
Toro Sainz MV, Garcia Gimenez MD, Pascual Martinez M (1987) Isolation and
identification of phenol acids from Erica andevalensis Cabezudo-Ribera: their
contribution to an antibacterial activity. Ann. Pharm. Françaises, 45: 401-407.
Tuzlacı E, Eryaşar Aymaz P (2001) Turkish folk medicinal plants, Part IV: Gönen
(Balıkesir). Fitoterapia, 72: 323-343.
Tzitsa E, Tzakou O, Loukis A (2000). Volatile constituents of Erica manipuliflora Salisb.
from Greece. J. Essent. Oil Res., 12: 67-68.
Vieitez E, Ballester A (1972) Phenolic and coumaric components in Erica cinerea. Anales
Inst. Bot. Cavanilles, 29: 129-142.
Villareal MO, Han J, Matsuyama K, Sekii Y, Smaoui A, Shigemori H, Isoda H (2013)
Lupenone from Erica multiflora leaf extract stimulates melanogenesis in B16 murine
melanoma cells through the inhibition of ERK1/2 activation. Planta Med., 79: 236-243.